<DOC>
	<DOC>NCT00002316</DOC>
	<brief_summary>To evaluate the safety of escalating doses of RMP-7 administered in persons with HIV infection and cryptococcal meningitis and to determine the MTD of the drug. To evaluate the pharmacokinetics, including cerebrospinal fluid (CSF) penetration, of amphotericin B when administered with RMP-7.</brief_summary>
	<brief_title>The Safety and Effectiveness of RMP-7 Plus Amphotericin B in Patients With HIV and Cryptococcal Meningitis</brief_title>
	<detailed_description>Patients receive intravenous RMP-7 added to conventional therapy with intravenous amphotericin B (with or without flucytosine). Treatment continues for 14 days, with follow-up visits 4 and 12 weeks later.</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Meningitis, Cryptococcal</mesh_term>
	<mesh_term>Amphotericin B</mesh_term>
	<mesh_term>Liposomal amphotericin B</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication: Allowed: Up to 1 mg/kg amphotericin B for the current episode of cryptococcal meningitis. Patients must have: HIV infection. Acute cryptococcal meningitis. Exclusion Criteria Coexisting Condition: Patients with the following symptoms or conditions are excluded: Cardiovascular disorders including congestive heart failure, uncontrolled hypertension (seated diastolic blood pressure &gt; 95 mm Hg), or symptomatic ischemic heart disease (angina). Orthostatic hypotension, defined as a decrease in systolic blood pressure of &gt;= 20 mm Hg upon standing. Coma. Other CNS disease (e.g., other intracranial infections) that may interfere with assessment of response. Opening CSF pressure &gt;= 350 mm or papilledema. (For patients with recurrent disease, evidence of mass effect on either MRI or CT excludes.) Any concurrent disease that would preclude participation in the study. Patients with the following prior conditions are excluded: History of any bleeding disorder. History of active renal or hepatic disease. Myocardial infarction within the previous 3 months. Stroke within the previous 3 months.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 1994</verification_date>
	<keyword>AIDS-Related Opportunistic Infections</keyword>
	<keyword>Meningitis</keyword>
	<keyword>Drug Therapy, Combination</keyword>
	<keyword>Antifungal Agents</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>Amphotericin B</keyword>
</DOC>